Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512) 2023-09-23T14:40:25+00:00 IJPS [email protected] Open Journal Systems <p><em><strong>Iraqi Journal of Pharmaceutical Sciences</strong> (IJPS)</em> is the official journal of the College of Pharmacy, University of Baghdad. The IJPS is a biannual specialized scientific journal which was first founded in 1979. The aim of this journal is to support scientific knowledge and encourage scientific research and publications. The IJPS provides a forum for reporting innovations, production methods, technologies, initiatives and the application of scientific knowledge to all aspects of pharmaceutical sciences, including advanced drug delivery systems, drug targeting, pharmacodynamics, pharmacokinetics, pharmacogenomics, biopharmaceutics, drug and prodrug design, pharmaceutical analysis, drug stability, quality control, pharmaceutical engineering, and pharmacy practice . <em><strong>The journal has issued thirty volumes and fifty three issues from 1979 until December of 2021.</strong></em></p> <p><em><strong>Iraqi Journal of Pharmaceutical Sciences (IJPS) </strong></em>is an open access peer-reviewed journal. Open access (OA) refers to a free and unrestricted online access to journal articles. The OA content is open to all with no access fees. For more information on Creative Commons license and the benefits of publishing an open access article</p> <p> </p> The Role of Clinical Pharmacist in Reducing Drug Related Problems in Decompensated Liver cirrhosis patients 2022-08-03T17:47:27+00:00 Ameer Alobeidi [email protected] Mohammed Y. Jamal [email protected] <p>Patients with decompensated cirrhosis have typically prescribed a combination of therapeutic and prophylactic medications. Polypharmacy increases the probability of medication errors and drug related problems.&nbsp;Clinical pharmacists are highly effective at identifying, resolving, and preventing clinically important drug-related problems in their patients' care.&nbsp;The objectives of the study were&nbsp;the identification and classification of drug-related problems, as well as the discussion of these problems with health care providers (physicians, pharmacists, and nurses) and patients. Reduce their incidence as effectively as possible and educate all research participants on the significance of following their prescribed drug regimen.&nbsp;Prospective, interventional, clinical study for 80 hospitalized decompensated liver cirrhosis patients was designed in&nbsp;two phases, an observational phase to identify drug related problems and classify them according to the Pharmaceutical Care Network Europe classification version 9.1,&nbsp;and an interventional phase to increase the awareness of patients and the health care providers about those problems and to propose a proper solution for each one.&nbsp;The majority of drug-related problems were attributable to the Effect of drug treatment not optimal in 41.5%, Adverse drug events (possibly) occurring in 41.5 %, and Untreated symptoms or indications in 17%. Causes were Drug dose too high&nbsp;in 30.2%,&nbsp;Patient unintentionally&nbsp;using the drug in the wrong way&nbsp;in 22.6%,&nbsp;and Prescribed drug not available&nbsp;in 13.2%. Omeprazole and lactulose were the most common medications causing problems.&nbsp;Acceptance and full implementation were high and observed in&nbsp;71.7% of pharmacist interventions while 15.1% of the intervention have no agreement.&nbsp;Significant numbers of Iraqi patients with decompensated liver cirrhosis have drug-related problems, and the use of proton pump inhibitors in too high dose was accountable for a large number of problems.&nbsp;Physicians and clinical pharmacists collaborated exceptionally well</p> 2023-09-23T00:00:00+00:00 Copyright (c) 2023 Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512) Effect of pharmacist interventions on pulmonary function parameters of Iraqi asthmatic patients: A comparative study 2022-08-13T21:09:25+00:00 Marwan S. Ibrahim [email protected] Mohammed Mahmood Mohammed [email protected] <p><strong>Background:</strong> Despite the fact that asthma is a long-term disease that may be treated, many people are unable to control their symptoms due to a lack of knowledge about their condition. The study's purpose was to find out if a pharmacist intervention improved asthma management because of this.</p> <p><strong>Objective:</strong> this study designed to assess the effect of pharmaceutical care on pulmonary functions test.</p> <p><strong>Method:</strong> The study was completed in three months. The patients who were enrolled were divided into two groups: <strong>Group 1</strong> consists of 23 asthma patients who were randomly assigned to receive conventional therapy for chronic bronchial asthma based on disease stage and severity, as well as a pharmaceutical care plan that includes patient care and education, for three months. <strong>Group 2:</strong> Included in the study were 21 asthma patients who were randomly randomized to receive only conventional therapy for chronic bronchial asthma based on illness stage and severity for three months. All individuals included in this trial had their ACT and PFT levels checked at the start and three months later.</p> <p><strong>Result: </strong>the conclusion of the study, patients who received a verbal and written pharmaceutical implementation plan significantly improved their asthma control by increasing medication adherence, which was accompanied by an improvement in mean ACT and PFT scores for the interventional group when compared to the control group after 3 months of follow up.</p> <p><strong>Conclusion: </strong>The results of the study approved the important role of the pharmacist in asthma control to improve medication adherence and enhancing PFT and this mean increase asthma control</p> 2023-09-23T00:00:00+00:00 Copyright (c) 2023 Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512)